Article
Drug Repositioning for HPV Clade-Specific Cervicouterine Cancer Using the OCTAD Pipeline
2025-10-07
Abstract excerpt
Cervical cancer remains a major global burden largely driven by persistent infection with high-risk human papillomavirus (HPV). Biological diversity across HPV phylogenetic clades (α-7 and α-9) may shape tumor programs and outcomes. To accelerate therapeutic options, we implemented an expression based, clade informed drug repurposing pipeline using OCTAD. We built disease signatures for HPV-α7 and HPV-α9 tumors, r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dd3ddedd-08b3-5eec-86ae-ea1574855abe
- DOI
- 10.20944/preprints202510.0320.v1
